The data available to date, describing the role played by BCL2 in transitional cell carcinoma (TCC) of the bladder, have been both limited and conflicting, with some studies showing an association with a lower tumour grade (King et al, 1996) and less aggressive phenotype (Shiina et al, 1996). The gene discussed is BCL2; the disease is transitional cell carcinoma.